Logo image of CHRO

CHANNEL THERAPEUTICS CORP (CHRO) Stock Analyst Ratings

NYSEARCA:CHRO - American Stock Exchange - US1711261057 - Common Stock

1.9  +0.94 (+97.92%)

After market: 2.06 +0.16 (+8.42%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CHRO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.67. This target is 356.32% above the current price.
CHRO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CHRO.
In the previous month the buy percentage consensus was at a similar level.
CHRO was analyzed by 7 analysts. More opinions would make the average more meaningful.
CHRO Historical Analyst RatingsCHRO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -6 -5 -4 -3 -2 -1 0 2 4 6

Price Target & Forecast

Price Low Median Mean High 1.908.598.678.678.93 - 351.84% 356.32% 356.32% 369.74%
CHRO Current Analyst RatingCHRO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-06-18 Alliance Global Partners Initiate Buy